sFSFI-sv elaboration | Test–retest reliability and criterion validity | |
---|---|---|
All patients | 114 | 93 |
Age (years), mean (SD) | 53.5 (14.9) | 54.9 (13.9) |
Education, N (%) | ||
None | 2 (1.8) | 2 (2.2) |
Elementary | 21 (18.4) | 18 (19.4) |
Secondary | 34 (29.8) | 26 (28) |
Higher | 57 (50) | 47 (50.5) |
Marital status, N (%) | ||
Single | 5 (4.4) | 5 (5.4) |
Married or steady partner | 96 (84.2) | 76 (81.7) |
Divorced | 7 (6.1) | 7 (7.5) |
Widow | 5 (4.4) | 5 (5.4) |
Children, N (%) | 90 (78.9) | 74 (79.6) |
Menopausal, N (%) | 70 (61.4) | 57 (61.3) |
Hormone replacement therapy, N (%) | 5 (4.4) | 4 (4.3) |
Reason for referral, N (%) | ||
Incontinence | 46 (40.3) | 39 (41.9) |
Pelvic organ prolapse | 13 (11.4) | 12 (12.9) |
Pelvic floor muscle dysfunction | 5 (4.4) | 4 (4.3) |
Pelvic pain | 10 (8.7) | 7 (7.5) |
Sexual dysfunction | 19 (16.7) | 15 (16.1) |
Others | 21 (18.4) | 16 (17.2) |
Comorbidities, N (%) | ||
Oncologic disease | 8 (7) | 7 (7.5) |
Neurologic disease | 4(3.5) | 4 (4.3) |
Depression | 19 (16.7) | 16 (17.2) |
Anxiety | 11 (9.6) | 9 (9.7) |
Prior pelvic surgery | 35 (30.7) | 29 (31.1) |
Frequency of sexual activity, N (%) | ||
> 4 per week | 1 (0.9) | 0 (0) |
3–4 per week | 3 (2.6) | 3 (3.2) |
1–2 per week | 33 (28.9) | 22 (23.7) |
1–2 per month | 42 (36.8) | 36 (38.7) |
< once per month | 35 (30.7) | 32 (34.4) |